Biochemically recurrent prostate cancer: 68Ga-RM2 (formerly known as 68Ga-Bombesin or BAY86-7548) PET/MRI is superior to conventional imaging

被引:0
|
作者
Iagaru, Andrei [2 ]
Minamimoto, Ryogo [2 ]
Loening, Andreas [2 ]
Mueller, Andre [1 ]
Berndt, Mathias [1 ]
Stephens, Andrew [1 ]
Vasanawala, Shreyas [2 ]
机构
[1] Piramal Imaging GmbH, Berlin, Germany
[2] Stanford Univ, Stanford, CA 94305 USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
466
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Physiological 68Ga-RM2 Uptake in Patients with Biochemically Recurrent Prostate Cancer: An Atlas of Semi-Quantitative Measurements
    Baratto, L.
    Duan, H.
    Laudicella, R.
    Ferri, V.
    Toriihara, A.
    Hatami, N.
    Iagaru, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S606 - S607
  • [22] Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements
    Lucia Baratto
    Heying Duan
    Riccardo Laudicella
    Akira Toriihara
    Negin Hatami
    Valentina Ferri
    Andrei Iagaru
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 115 - 122
  • [23] Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements
    Baratto, Lucia
    Duan, Heying
    Laudicella, Riccardo
    Toriihara, Akira
    Hatami, Negin
    Ferri, Valentina
    Iagaru, Andrei
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (01) : 115 - 122
  • [24] Prospective Comparison of 68 Ga-NeoB and 68 Ga-PSMA-R2 PET/MRI in Patients with Biochemically Recurrent Prostate Cancer
    Duan, Heying
    Song, Hong
    Davidzon, Guido A.
    Moradi, Farshad
    Liang, Tie
    Loening, Andreas
    Vasanawala, Shreyas
    Iagaru, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (06) : 897 - 903
  • [25] Prospective comparison of 68Ga-RM2 PET/CT and 68Ga-PSMA-617 PET/CT for initial staging of prostate cancer
    Schollhammer, Romain
    De Clermont-Gallerande, Henri
    Robert, Gregoire
    Yacoub, Mokrane
    Lamare, Frederic
    Balamoutoff, Nicolas
    Vimont, Delphine
    Hindie, Elif
    Fernandez, Philippe
    Morgat, Clement
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [26] Prospective comparison of 68Ga-RM2 PET/CT and 68Ga-PSMA-617 PET/CT for initial staging of prostate cancer
    Schollhammer, R.
    Gallerande, H. De Clermont
    Robert, G.
    Yacoub, M.
    Lamare, F.
    Balamoutoff, N.
    Vimont, D.
    Hindie, E.
    Fernandez, P.
    Morgat, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S279 - S279
  • [27] Radiometabolism, whole-body distribution and radiation dosimetry of Ga-68-bombesin antagonist BAY86-7548 in healthy men
    Roivainen, A.
    Kahkonen, E.
    Borkowski, S.
    Hofmann, B.
    Lehtio, K.
    Luoto, P.
    Rantala, T.
    Rottmann, A.
    Sipila, H.
    Sparks, R.
    Suilamo, S.
    Tolvanen, T.
    Valencia, R.
    Minn, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S591 - S591
  • [28] 68Ga-RM2 PET vs. 68Ga-PSMA-11 PET: Prospective Comparison in Patients with Biochemical Recurrence of Prostate Cancer
    Baratto, L.
    Duan, H.
    Minamimoto, R.
    Mari, C.
    Yohannan, T.
    Davidzon, G.
    Iagaru, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S151 - S151
  • [29] Ga68 RM2 PET/MRI Evaluation of Gastrin-Releasing Peptide Receptor Status in Patients with Biochemically Recurrent Prostate Cancer and Negative Conventional Imaging
    Iagaru, A.
    Sonni, I.
    Minamimoto, R.
    Loening, A.
    Vasanawala, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S28 - S28
  • [30] Preclinical validation of the Ga-68-bombesin antagonist BAY 86-7548 for a phase I study in prostate cancer patients
    Borkowski, Sandra
    Doehr, Olaf
    Hultsch, Christina
    Weinig, Peter
    Elger, Bernd
    Hegele-Hartung, Christa
    Graham, Keith
    Dinkelborg, Ludger
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53